Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically

Annals of Thoracic Surgery

Volumn 68, Issue 5, 1999, Pages 1799-1804

  Rusch, Valerie W ^a   Venkatraman, Ennapadam S ^b  

^a Thoracic Service   (United States)

^b Division of Biostatistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032732861     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01038-3     Document Type: Article

References (21)

1. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma results of 183 patients . J Thorac Cardiovasc Surg. 117:1999;54-65.
2. Rusch V.W., Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 111:1996;815-826.
3. Chailleux E., Dabouis G., Pioche D., et al. Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. Chest. 93:1988;159-162.
4. Sugarbaker D.J., Garcia J.P., Richards W.G., et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 224:1996;288-296.
5. Ruffie R., Feld R., Minkin S., et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec a retrospective study of 332 patients . J Clin Oncol. 7:1989;1157-1168.
6. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest. 108:1995;1122-1128.
7. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
8. Mantel N., Haentzel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst. 22:1958;718-748.
9. Cox D.R. Regression models and life tables. [with discussion] J R Stat Soc B. 34:1972;187-220.
10. Mountain C.F. A new international staging system for lung cancer. Chest. 89:(Suppl):1986;225-233.
11. Casson A.G., Rusch V.W., Ginsberg R.J., Zankowicz N., Finley R.J. Lymph node mapping of esophageal cancer. Ann Thorac Surg. 58:1994;1569-1570.
12. Tammilehto L., Kivisaari L., Salminen U.S., Maasilta P., Mattson K. Evaluation of the clinical TNM staging system for malignant pleural mesothelioma an assessment in 88 patients . Lung Cancer. 12:1995;25-34.
13. Pass H.I., Kranda K., Temeck B.K., Feuerstein I., Steinberg S.M. Surgically debulked malignant pleural mesothelioma results and prognostic factors . Ann Surg Oncol. 4:1997;215-222.
14. Boutin C., Rey F., Gouvernet J., Viallat J.-R., Astoul P., Ledoray V. Thoracoscopy in pleural malignant mesothelioma a prospective study of 188 consecutive patients. Part 2: prognosis and staging . Cancer. 72:1993;394-404.
15. Baldini E.H., Recht A., Strauss G.M., et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 63:1997;334-338.
16. Conlon K.C., Rusch V.W., Gillern S. Laparoscopy an important tool in the staging of malignant pleural mesothelioma . Ann Surg Oncol. 3:1996;489-494.
17. Heelan R.T., Rusch V.W., Begg C.B., Panicek D.M., Caravelli J.F., Eisen C. Malignant pleural mesothelioma comparison of CT and MR imaging for staging . AJR. 172:1999;1039-1047.
18. Rusch V.W., Piantadosi S., Holmes E.C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 102:1991;1-9.
19. Sugarbaker D.J., Heher E.C., Lee T.H., et al. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 102:1991;10-15.
20. Allen K.B., Faber L.P., Warren W.H. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin North Am. 4:1994;113-126.
21. Sugarbaker D.J., Strauss G.M., Lynch T.J., et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol. 11:1993;1172-1178.